1 / 4

Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Comp

The global immune-mediated inflammatory disease treatment market is anticipated to grow at a CAGR of over 6% during the forecast period. Immune-mediated inflammatory disease treatment has been improved significantly over the past years due to the development of a series of targeted biological therapies and novel therapies in the market.

Meenoo
Download Presentation

Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Comp

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Immune-Mediated Inflammatory Diseases Treatment Market, Size, Share, Analysis Report & Forecast to 2025 To Request a Sample of our Report on Global Immune-Mediated Inflammatory Diseases Treatment Market: https://www.omrglobal.com/request-sample/immune-mediated-inflammatory-diseases- treatment-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global immune-mediated inflammatory disease treatment market is anticipated to grow at a CAGR of over 6% during the forecast period. Immune-mediated inflammatory disease treatment has been improved significantly over the past years due to the development of a series of targeted biological therapies and novel therapies in the market. Currently, quite a lot of research is going on in the field regarding the treatment of immune-mediated disease. In addition, new drugs and treatment options are entering the market, which is fuelling the growth of the global immune-mediated inflammatory disease treatment market. For instance, in August 2019, the US FDA approved upadacitinib (Rinvoq), an oral medication for adults with moderate to severe rheumatoid arthritis that is not being well-controlled by methotrexate. (Get 15% Discount on Buying this Report) A full Report of Global Immune-Mediated Inflammatory Diseases Treatment Market is Available at: https://www.omrglobal.com/industry-reports/immune-mediated-inflammatory-diseases- treatment-market However, the late diagnosis of immune-mediated inflammatory disease coupled with challenges during the treatment such as slow or incomplete healing is limiting the growth of the global immune-mediated inflammatory disease treatment market. In addition, the high cost associated with the treatment also restricts the global immune-mediated inflammatory disease treatment market growth. For instance, due to their high costs, considerable differences in the utilization of treatment options exist across the globe. Various European countries are restricting access despite professional society guideline recommendations. Additionally, the adoption of biologic therapies for the treatment by healthcare providers has been particularly poor in many Central and Eastern European countries which are affecting the growth of immune-mediated inflammatory diseases. Moreover, the presence of a small patient base for rare disease coupled with disproportion in the availability of treatments and resources to manage patients, and train experts in developing economies will also limit the growth of the global immune- mediated inflammatory diseases treatment market. To Request a Sample of our Report on Global Immune-Mediated Inflammatory Diseases Treatment Market: https://www.omrglobal.com/request-sample/immune-mediated-inflammatory-diseases- treatment-market Global Immune-Mediated Inflammatory Diseases Treatment Market Segmentation By Disease Type •Multiple Sclerosis •Psoriasis •Inflammatory Bowel Disease •Rheumatoid Arthritis •Others By Drug Class •Anti- Inflammatory Biologics •Non- Steroidal Anti- Inflammatory Drugs •Corticosteroids By Treatment Type •Targeted Biologic Therapies

  3. •Novel Therapies Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India •China •Japan •Rest of APAC Rest of The World Company Profiles •Abbvie Inc. •Abivax SA •AstraZeneca PLC •Boehringer Ingelheim International GmbH •Bristol-Myers Squibb Co. •Celgene Corp. •Daiichi Sankyo Co., Ltd. •Eli Lilly and Co. •F. Hoffmann-La Roche Ltd. •Gilead Sciences, Inc. •GlaxoSmithKline PLC •Innovate Biopharmaceuticals Inc. •Johnson & Johnson Services Inc. •LG Chem Ltd. •Merck & Co., Inc. •Merck KGaA •Novartis International AG •Pharmaxis Ltd. •Sanofi S.A. •UCB S.A. •Ventria Bioscience Inc.

  4. Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immune-mediated-inflammatory-diseases- treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related